Antibacterial potential of some seaweeds species to combat biofilm-producing multi-drug resistant Staphylococcus aureus of Nile Tilapia
THERE is an increasing worldwide demand for seafood due to the awareness of fish as an
important protein source for a growing population. However, the diseases caused by multi …
important protein source for a growing population. However, the diseases caused by multi …
[PDF][PDF] Virulence factors profile of Staphylococcus aureus isolated from different clinical sources
In this study, a number of 85 Staphylococcus aureus isolates were collected from various
clinical sources including diabetic foot, burns, urine, wound, abcesses, boils, nasal …
clinical sources including diabetic foot, burns, urine, wound, abcesses, boils, nasal …
Combination of clot buster enzymes and herbal extracts: a new alternative for thrombolytic drugs
Herbal preparations have been used since ancient times for the treatment of several
diseases and constitute a major share of all the officially recognized systems of health in …
diseases and constitute a major share of all the officially recognized systems of health in …
[PDF][PDF] Screening of staphylokinase producing Staphylococcus aureus from clinical samples
B Shagufta Naseer, M Ravi… - Int J Res Biol …, 2014 - researchgate.net
Thrombolytic agents play an important role in the treatment of cardiovascular diseases
which are the main causes of mortality and morbidity. The search for efficient thrombolytic …
which are the main causes of mortality and morbidity. The search for efficient thrombolytic …
[HTML][HTML] Bioprospecting of Clot Buster Enzyme Producing Staphylococcus sp from Bovine Milk Sample
V Mohanasrinivasan, G Rawat, A Parashar… - Research Journal of …, 2018 - rjptonline.org
The current study was intended to mitigate the risks posed by Cardiovascular heart diseases
(CVD) which is the major cause of mortality and morbidity in the recent years around the …
(CVD) which is the major cause of mortality and morbidity in the recent years around the …
Evaluation on Clot Buster Activity of Staphylokinase from Staphylococcus sp.
V Mohanasrinivasan, C Subathra Devi… - … Agents in Medicinal …, 2014 - ingentaconnect.com
Thrombolytic agents play a major role in the treatment of cardiovascular diseases.
Streptokinase is the prominently commercialized thrombolytic drug used for the treatment of …
Streptokinase is the prominently commercialized thrombolytic drug used for the treatment of …
[PDF][PDF] Production of fibrinolytic Staphylokinase from UV Mutated Staphylococcus aureus VITSDVM7
F Siddiqui, P Lakshmi, S Jemimah Naine - academia.edu
Staphylokinase is an extracellular protein produced by strains of Staphylococcus aureus
which digest fibrin clots. Hence it is widely used as thrombolytic agent due to its low cost as …
which digest fibrin clots. Hence it is widely used as thrombolytic agent due to its low cost as …